Home › Funds › Affinity Asset Advisors, LLC › ANAB

Affinity Asset Advisors, LLC position in ANAB

ANAPTYSBIO INC COM · Health Care

Affinity Asset Advisors, LLC reported holding 826,109 shares of ANAB (ANAPTYSBIO INC COM) in its Q2 2026 13F filing — a position valued at US$55.8M, representing 2.68% of its reported portfolio and ranking #9 among its reported holdings. Affinity Asset Advisors, LLC has disclosed ANAB holdings in 4 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)826.11K sh
Reported value held$55.76M
Portfolio Weight2.68%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's ANAB position evolved

Affinity Asset Advisors, LLC first disclosed a stake in ANAB in Q3 2024 at 200,000 shares (US$6.7M). The position peaked in Q2 2026 at 826,109 shares, worth US$55.8M. Across 4 filings, Affinity Asset Advisors, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 826,109 shares valued at US$55.8M — a reduction of -113,891 shares quarter over quarter.. Notable position changes include a 111% increase in Q1 2026 (shares rose 83% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 200.00K $6.70M New
Q4 2025 444.69K $21.56M New
Q1 2026 940.00K $52.13M Add
Q2 2026 826.11K $55.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANAB and 13F data

ANAB (ANAPTYSBIO INC COM) is a Health Care company. 46 other funds we track also report a position in ANAB — the largest reported positions include EcoR1 Capital, LLC (US$531.9M), TANG CAPITAL MANAGEMENT LLC (US$89.8M), Sanofi (US$55.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANAB

All ANAB fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held ANAB?

Affinity Asset Advisors, LLC has disclosed ANAB holdings in 4 of the last 8 reported quarters, going back to Q3 2024.

What is Affinity Asset Advisors, LLC's current position in ANAB?

As of Q2 2026, Affinity Asset Advisors, LLC holds 826.11K shares of ANAB (ANAPTYSBIO INC COM), valued at $55.76M, representing 2.68% of its reported portfolio and ranking #9.

Has Affinity Asset Advisors, LLC been buying or selling ANAB?

In the latest 13F filing (Q2 2026), Affinity Asset Advisors, LLC reduced its position in ANAB. The position peaked in Q2 2026 at 826.11K shares.

Which other funds hold ANAB?

Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Sanofi, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.